230 related articles for article (PubMed ID: 36647077)
21. Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version.
Kolotkin RL; Williams VSL; Ervin CM; Williams N; Meincke HH; Qin S; von Huth Smith L; Fehnel SE
Clin Obes; 2019 Jun; 9(3):e12310. PubMed ID: 30993900
[TBL] [Abstract][Full Text] [Related]
22. Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies.
Wabitsch M; Fehnel S; Mallya UG; Sluga-O'Callaghan M; Richardson D; Price M; Kühnen P
Adv Ther; 2022 Apr; 39(4):1772-1783. PubMed ID: 35192151
[TBL] [Abstract][Full Text] [Related]
23. Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies.
Kolotkin RL; Ervin CM; Meincke HH; Højbjerre L; Fehnel SE
Clin Obes; 2017 Oct; 7(5):290-299. PubMed ID: 28544443
[TBL] [Abstract][Full Text] [Related]
24. Bardet-Biedl syndrome: a case series.
Elawad OAMA; Dafallah MA; Ahmed MMM; Albashir AAD; Abdalla SMA; Yousif HHM; Daw Elbait AAE; Mohammed ME; Ali HIH; Ahmed MMM; Mohammed NFN; Osman FHM; Mohammed MAY; Abu Shama EAE
J Med Case Rep; 2022 Apr; 16(1):169. PubMed ID: 35484558
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome.
Forsythe E; Sparks K; Best S; Borrows S; Hoskins B; Sabir A; Barrett T; Williams D; Mohammed S; Goldsmith D; Milford DV; Bockenhauer D; Foggensteiner L; Beales PL
J Am Soc Nephrol; 2017 Mar; 28(3):963-970. PubMed ID: 27659767
[TBL] [Abstract][Full Text] [Related]
26. Sleep and physical activity patterns in adults and children with Bardet-Biedl syndrome.
Pomeroy J; VanWormer JJ; Meilahn JR; Maki T; Murali HR; Haws RM
Orphanet J Rare Dis; 2021 Jun; 16(1):276. PubMed ID: 34127036
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life in randomized controlled trials of lorcaserin for obesity management: what mediates improvement?
Kolotkin RL; Crosby RD; Wang Z
Clin Obes; 2017 Dec; 7(6):347-353. PubMed ID: 28815987
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?
Kolotkin RL; Gadde KM; Peterson CA; Crosby RD
Qual Life Res; 2016 May; 25(5):1237-44. PubMed ID: 26446094
[TBL] [Abstract][Full Text] [Related]
29. Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.
Roth CL; Scimia C; Shoemaker AH; Gottschalk M; Miller J; Yuan G; Malhotra S; Abuzzahab MJ
Lancet Diabetes Endocrinol; 2024 Jun; 12(6):380-389. PubMed ID: 38697184
[TBL] [Abstract][Full Text] [Related]
30. 12-year trajectory of health-related quality of life in gastric bypass patients versus comparison groups.
Kolotkin RL; Kim J; Davidson LE; Crosby RD; Hunt SC; Adams TD
Surg Obes Relat Dis; 2018 Sep; 14(9):1359-1365. PubMed ID: 29884519
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P;
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293
[TBL] [Abstract][Full Text] [Related]
32. Improvements in health-related quality of life with liraglutide 3.0 mg compared with placebo in weight management.
Kolotkin RL; Fujioka K; Wolden ML; Brett JH; Bjorner JB
Clin Obes; 2016 Aug; 6(4):233-42. PubMed ID: 27198973
[TBL] [Abstract][Full Text] [Related]
33. The importance of renal impairment in the natural history of Bardet-Biedl syndrome.
O'Dea D; Parfrey PS; Harnett JD; Hefferton D; Cramer BC; Green J
Am J Kidney Dis; 1996 Jun; 27(6):776-83. PubMed ID: 8651240
[TBL] [Abstract][Full Text] [Related]
34. A diagnostic conundrum in Bardet-Biedl syndrome: when genetic diagnosis precedes clinical diagnosis.
Van Roy N; Heerwegh S; Husein D; Ruys J; Coremans P
Endocrinol Diabetes Metab Case Rep; 2023 Oct; 2023(4):. PubMed ID: 37997784
[TBL] [Abstract][Full Text] [Related]
35. Effect of adjustable gastric banding on quality of life and weight loss in the Helping Evaluate Reduction in Obesity (HERO) registry study: 2 year analysis.
Lao WL; Malone DC; Armstrong EP; Voellinger D; Somers S; Jin J; Dreyer N; Globe D
Curr Med Res Opin; 2015 Aug; 31(8):1451-60. PubMed ID: 26154653
[TBL] [Abstract][Full Text] [Related]
36. Performance of a weight-related measure of Quality of Life in a psychiatric sample.
Kolotkin RL; Crosby RD; Corey-Lisle PK; Li H; Swanson JM
Qual Life Res; 2006 May; 15(4):587-96. PubMed ID: 16688492
[TBL] [Abstract][Full Text] [Related]
37. Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT).
Kolotkin RL; Williams VSL; von Huth Smith L; Meincke HH; Qin S; Williams N; Fehnel SE
Clin Obes; 2021 Oct; 11(5):e12477. PubMed ID: 34296522
[TBL] [Abstract][Full Text] [Related]
38. Renal features of Bardet Biedl syndrome: A single center experience.
Atmış B; Karabay-Bayazıt A; Melek E; Bişgin A; Anarat A
Turk J Pediatr; 2019; 61(2):186-192. PubMed ID: 31951329
[TBL] [Abstract][Full Text] [Related]
39. Pigmentary retinopathy due to Bardet-Biedl syndrome: case report and literature review.
Andrade LJ; Andrade R; França CS; Bittencourt AV
Arq Bras Oftalmol; 2009; 72(5):694-6. PubMed ID: 20027412
[TBL] [Abstract][Full Text] [Related]
40. Next-Generation Sequencing in the Diagnosis of Patients with Bardet-Biedl Syndrome-New Variants and Relationship with Hyperglycemia and Insulin Resistance.
Jeziorny K; Antosik K; Jakiel P; Młynarski W; Borowiec M; Zmysłowska A
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33138063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
